UBS O'Connor »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by UBS O'Connor

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by UBS O'Connor from 13F filings

Historical chart of UBS O'Connor investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by UBS O'Connor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by UBS O'Connor

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.9M 7.0M 1.41
2025-06-30 $26M 23M 1.14
2025-03-31 $19M 15M 1.29

More positions owned by UBS O'Connor

Verona Pha Spons (VRNA)
Mr Cooper Group
NVIDIA Corporation (NVDA)
Snowflake Note1 (Principal)
Spirit Aer Comcl (SPR)
Peloton In Note2 (Principal)
Halozyme T Note0 (Principal)
Alliant Energy Corporation (LNT)
Draftkings Note3 (Principal)
Southern C Note4 (Principal)
Entergy Corporation (ETR)
Southern Company (SO)
Packaging Corporation of America (PKG)
Duke Energ Note4 (Principal)
American W Note3 (Principal)

View all positions for UBS O'Connor

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
LMR Partners
Calamos Advisors
Camden Asset Management
Balyasny Asset Management
DLD Asset Management
Point72 Asset Management
Davidson Kempner Capital Management
Jpmorgan Chase & Co
Jain Global
Nuveen
Lazard Asset Management
State Street Corporation
Absolute Investment Advisers
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1